Orphenadrine Citrate NDC 50090-0169

Product information

Brand name (proprietary)

Orphenadrine Citrate

Generic name (nonproprietary)

orphenadrine citrate

Active ingredients

Orphenadrine citrate — 100 mg/1

Dosage form

Tablet, Extended release

Route

Oral

Labeler

A-S Medication Solutions

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 040284

Marketing start

Jun 19, 1998

Listing expires

Dec 31, 2027

Other FDA classes

Centrally-mediated Muscle Relaxation (Physiologic effect)

Identifiers

Product ID 50090-0169_a11270c6-fe5e-4cfd-9a1e-f11abb0fe4a0SPL ID a11270c6-fe5e-4cfd-9a1e-f11abb0fe4a0SPL set ID 80ef7fb4-7c50-4d25-915e-f9d4a2ccd199RxCUI 994521UNII X0A40N8I4S

Pharmacologic class

Muscle Relaxant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090016900 followed by a unit qualifier and the quantity Copy

Package 50090-0169-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 040284

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.